Livestock products contribute 33% to protein consumption globally; however, this figure varies across developed and developing countries. The general livestock sector is predicted to witness significant growth because of the high consumption of animal-derived food products. With the growing consumption of animal-derived food products, the utilization of antimicrobials and antibiotics is predicted to extend to need care of animal health.
Intensive usage of antimicrobials within the management of animal diseases results in resistance among microorganisms. The resistant clones of bacteria are found globally. Antibiotic and antimicrobial resistance may be a burning issue within the animal health market. To tackle this issue, most farmers and pet owners tend to extend the dosage of antibiotics and antimicrobials or change the antibiotics and antimicrobials used. However, these practices may prove detrimental within the end of the day and end in multi-drug-resistant microorganism species.
Antibiotic-resistant bacteria in livestock are a serious concern. Food-producing animals function a reservoir of resistant pathogens which will be transmitted from animals to humans via direct contact between animals and humans or through the organic phenomenon and therefore the environment.
Covid-19 Impact on Animal Antibiotics and Antimicrobials Market:
In addition, the present Global Market study offers an in depth analysis of the present COVID-19 pandemic impact on the market growth and its influence on the longer term growth of the worldwide Market. The recently published report demonstrates the elevation within the demand for the healthcare sector. The healthcare manufacturers have experienced future also as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. Additionally to this, panic conditions have already spurred the demand for several healthcare products and services which are discussed intimately during this report. Moreover, the impact of this pandemic on overall market revenue for the bottom year 2020 and its projection up to 2027 is provided intimately during this report.
Animal Antibiotics and Antimicrobials Market Segment Overview
By Antibiotics and Antimicrobials, Tetracyclines segmented major market share in predicted time. Tetracyclines exhibit advantages like the best potency against pathogenic microorganisms, are well-absorbed, show low toxicity, and are relatively inexpensive compared to other animal antimicrobial and antibiotic products. These advantages contribute to the massive share of this product segment.
By Mode of Application, The big share of this segment is often attributed to the benefits of premixes, like simplified mode of administration and lower instability and hygroscopicity of formulations.
By Animal, The big share of this segment is especially because of the rising demand for animal-derived food products, increase in animal healthcare expenditure, and greater concerns about zoonotic diseases.
Market Analysis, Insights and Forecast – By Antibiotics and Antimicrobials
· Tetracyclines
· Penicillins
· Sulfonamides
· Macrolides
· Aminoglycosides
· Lincosamides
· Fluoroquinolones
· Cephalosporins
· Other
Market Analysis, Insights and Forecast – By Mode of Application
· Premixes
· Oral Powder
· Oral Solution
· Injection
· Others
Market Analysis, Insights and Forecast – By Animal
· Food producing
· Companion
Animal Antibiotics and Antimicrobials Market Regional Overview
Region-wise, in terms of regions, In addition, the present Global Market study offers an in depth analysis of the present COVID-19 pandemic impact on the market growth and its influence on the longer term growth of the worldwide Market. The recently published report demonstrates the elevation within the demand for the healthcare sector. The healthcare manufacturers have experienced future also as short term effect which incorporates supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption might be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and makers to the limit. In addition to the present, panic conditions have already spurred the demand for several healthcare products and services which are discussed intimately during this report. Moreover, the impact of this pandemic on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Animal Antibiotics and Antimicrobials Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Animal Antibiotics and Antimicrobials Market Competitor overview
Some key developments and strategies adopted by manufacturers in the Animal Antibiotics and Antimicrobials are highlighted below.
· In 2020, Zoetis acquired Trianni Inc. to develop transgenic antibody platforms for the invention of latest veterinary treatments.
Animal Antibiotics and Antimicrobials Market, Key Players
· Boehringer Ingelheim
· Zoetis Inc.
· Elanco Animal Health
· Merck & Co. Inc.
· Phibro Animal Health
· Virbac
· Vetoquinol SA
· HIPRA
· Ceva Santé Animale
· Dechra Pharmaceuticals Plc
· Kyoritsu Seiyaku
· Tianjin Ringpu
· China Animal Husbandry
· Endovac Animal Health
· Zydus
· Indian Immunologicals Pvt. Ltd.
· UCBVET
· American Reagent Inc.
· Neogen Corporation
· Huvepharma Inc.
· Ayurvet
· Ashish Life Science
· Inovet
· Lutim Pharma
· ECO Animal Health
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Animal Antibiotics and Antimicrobials Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Antibiotics and Antimicrobials
- 5.2.1. Tetracyclines
- 5.2.2. Penicillins
- 5.2.3. Sulfonamides
- 5.2.4. Macrolides
- 5.2.5. Aminoglycosides
- 5.2.6. Lincosamides
- 5.2.7. Fluoroquinolones
- 5.2.8. Cephalosporins
- 5.2.9. Other
- 5.3. Market Analysis, Insights and Forecast – By Mode of Application
- 5.3.1. Premixes
- 5.3.2. Oral Powder
- 5.3.3. Oral Solution
- 5.3.4. Injection
- 5.3.5. Others
- 5.4. Market Analysis, Insights and Forecast – By Animal
- 5.4.1. Food producing
- 5.4.2. Companion
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America, Middle East, and Africa
6. North America Animal Antibiotics and Antimicrobials Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Antibiotics and Antimicrobials
- 6.2.1. Tetracyclines
- 6.2.2. Penicillins
- 6.2.3. Sulfonamides
- 6.2.4. Macrolides
- 6.2.5. Aminoglycosides
- 6.2.6. Lincosamides
- 6.2.7. Fluoroquinolones
- 6.2.8. Cephalosporins
- 6.2.9. Other
- 6.3. Market Analysis, Insights and Forecast – By Mode of Application
- 6.3.1. Premixes
- 6.3.2. Oral Powder
- 6.3.3. Oral Solution
- 6.3.4. Injection
- 6.3.5. Others
- 6.4. Market Analysis, Insights and Forecast – By Animal
- 6.4.1. Food producing
- 6.4.2. Companion
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Animal Antibiotics and Antimicrobials Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Antibiotics and Antimicrobials
- 7.2.1. Tetracyclines
- 7.2.2. Penicillins
- 7.2.3. Sulfonamides
- 7.2.4. Macrolides
- 7.2.5. Aminoglycosides
- 7.2.6. Lincosamides
- 7.2.7. Fluoroquinolones
- 7.2.8. Cephalosporins
- 7.2.9. Other
- 7.3. Market Analysis, Insights and Forecast – By Mode of Application
- 7.3.1. Premixes
- 7.3.2. Oral Powder
- 7.3.3. Oral Solution
- 7.3.4. Injection
- 7.3.5. Others
- 7.4. Market Analysis, Insights and Forecast – By Animal
- 7.4.1. Food producing
- 7.4.2. Companion
- 7.5. Market Analysis, Insights and Forecast – By Country
- 7.5.1. UK
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Russia
- 7.5.7. Rest of Europe
8. Asia Pacific Animal Antibiotics and Antimicrobials Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Antibiotics and Antimicrobials
- 8.2.1. Tetracyclines
- 8.2.2. Penicillins
- 8.2.3. Sulfonamides
- 8.2.4. Macrolides
- 8.2.5. Aminoglycosides
- 8.2.6. Lincosamides
- 8.2.7. Fluoroquinolones
- 8.2.8. Cephalosporins
- 8.2.9. Other
- 8.3. Market Analysis, Insights and Forecast – By Mode of Application
- 8.3.1. Premixes
- 8.3.2. Oral Powder
- 8.3.3. Oral Solution
- 8.3.4. Injection
- 8.3.5. Others
- 8.4. Market Analysis, Insights and Forecast – By Animal
- 8.4.1. Food producing
- 8.4.2. Companion
- 8.5. Market Analysis, Insights and Forecast – By Country
- 8.5.1. China
- 8.5.2. India
- 8.5.3. Japan
- 8.5.4. Australia
- 8.5.5. South East Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America, Middle East, and Africa Animal Antibiotics and Antimicrobials Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Antibiotics and Antimicrobials
- 9.2.1. Tetracyclines
- 9.2.2. Penicillins
- 9.2.3. Sulfonamides
- 9.2.4. Macrolides
- 9.2.5. Aminoglycosides
- 9.2.6. Lincosamides
- 9.2.7. Fluoroquinolones
- 9.2.8. Cephalosporins
- 9.2.9. Other
- 9.3. Market Analysis, Insights and Forecast – By Mode of Application
- 9.3.1. Premixes
- 9.3.2. Oral Powder
- 9.3.3. Oral Solution
- 9.3.4. Injection
- 9.3.5. Others
- 9.4. Market Analysis, Insights and Forecast – By Animal
- 9.4.1. Food producing
- 9.4.2. Companion
- 9.5. Market Analysis, Insights and Forecast – By Country
- 9.5.1. Brazil
- 9.5.2. Saudi Arabia
- 9.5.3. UAE
- 9.5.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Boehringer Ingelheim
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Zoetis Inc.
- 10.6. Elanco Animal Health
- 10.7. Merck & Co. Inc.
- 10.8. Phibro Animal Health
- 10.9. Virbac
- 10.10. Vetoquinol SA
- 10.11. HIPRA
- 10.12. Ceva Santé Animale
- 10.13. Dechra Pharmaceuticals Plc
- 10.14. Kyoritsu Seiyaku
- 10.15. Tianjin Ringpu
- 10.16. China Animal Husbandry
- 10.17. Endovac Animal Health
- 10.18. Zydus
- 10.19. Indian Immunologicals Pvt. Ltd.
- 10.20. UCBVET
- 10.21. American Reagent Inc.
- 10.22. Neogen Corporation
- 10.23. Huvepharma Inc.
- 10.24. Ayurvet
- 10.25. Ashish Life Science
- 10.26. Inovet
- 10.27. Lutim Pharma
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
